Genetic Test Can Identify Triple Negative Breast Cancer Treatment Responders

A test including 53 genes can predict who will respond and who will not respond to triple negative breast cancer immunotherapy.

Recent advances in therapeutic strategies for triple-negative

Proteogenomics reveals markers of chemotherapy resistance and

Novel Procedure Could Allow for Removal of Previously Inoperable

Looking Behavior Diagnoses Autism in Children 16 to 30 Months Old

How Common Is Triple-Positive Breast Cancer?

ENPP1 Enzyme Emerges as a Crucial On/Off Switch in Breast Cancer

Inside Precision Medicine on LinkedIn: Precision Immuno-Oncology

Mount Sinai Team Identify 4,729 Gene Clusters That Influence

Triple Negative Breast Cancer Clinic

Research Reveals New Avenues for Triple-Negative Breast Cancer

Quest, Ultima Genomics Ink Oncology Diagnostics Collaboration

In Conversation with Rosalind Eeles

Targeting oncogenic vulnerabilities in triple negative breast

Breast Cancer Tumor-Marker Tests

Courtney Noah, PhD on LinkedIn: #2023sot